Perwaiz Meraj, MD
Interventional Cardiology · Manhasset, NYNPI 1104088962
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Abiomed at 37.4% of the total.
Across 195 payments — averaging $379.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$28K
- Magenta Medical Inc$14K
- Cardiovascular Systems Inc.$10K
- Medtronic$6K
- Biotronik Inc.$5K
- Spectrawave, Inc$3K
- plus $9K from 21 others
Across 34 payments — averaging $3638.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$69K
- Magenta Medical Inc$42K
- Bayer$12K
What the payments were for
- Consulting fees$18,75025%
- Speaking & faculty fees$42,71758%
- Travel & lodging$4,7606%
- Food & beverage$7,71310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 38 | $27,677 |
| Magenta Medical Inc | 5 | $13,638 |
| Cardiovascular Systems Inc. | 29 | $10,456 |
| Medtronic(2 entities) | 36 | $5,551 |
| Biotronik Inc. | 5 | $5,035 |
| Spectrawave, Inc | 12 | $3,017 |
| Cathworks, Inc. | 2 | $2,633 |
| Boston Scientific | 9 | $1,379 |
| ZOLL Circulation Inc | 7 | $1,136 |
| Celonova Biosciences, Inc. | 1 | $800 |
| Abbott | 13 | $540 |
| Shockwave Medical, Inc | 16 | $479 |
| Philips North America LLC | 4 | $379 |
| Teleflex LLC | 4 | $236 |
| Terumo Medical Corporation | 1 | $149 |
| Livanova USA, Inc. | 1 | $133 |
| Alnylam Pharmaceuticals Inc. | 1 | $123 |
| Amgen | 1 | $113 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $111 |
| Edwards Lifesciences | 1 | $107 |
| Penumbra, Inc. | 2 | $103 |
| Angiodynamics, Inc. | 1 | $37 |
| Heartflow, Inc. | 1 | $28 |
| Cardiva Medical, Inc. | 1 | $25 |
| W. L. Gore & Associates, Inc. | 1 | $25 |
| Siemens Medical Solutions USA, Inc. | 1 | $15 |
| Pinnacle Biologics, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$27,244
- Coronary Orbital Atherectomy System$5,875
- Diamondback Coronary$4,114
- HyperVue Imaging System$2,895
- Starlight Imaging Catheter$2,895
- X1-FFR$2,750
- FFRangio$2,633
- Resolute$2,139
- Diamondback Peripheral$2,089
- TherOx DS2 Console$1,017
- Catheter$1,017
- Downstream Cartridge$1,017
- GENERAL VASCULAR ACCESS$750
- Onyx$614
- Peripheral Orbital Atherectomy System$272
- CoreValve Evolut$190
- PK Papyrus$175
- Orsiro Mission$175
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$156
- AMPLATZER Occluders$152
How this compares
$73,941 in reported general payments places this provider in the 85th percentile of 382 interventional cardiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 18 | $29,476 |
| EliquisApixaban | 21 | $18,154 |
| ClopidogrelClopidogrel Bisulfate | 94 | $1,097 |
| Atorvastatin Calcium | 108 | $1,060 |
| Carvedilol | 113 | $953 |
| Metoprolol Succinate | 37 | $436 |
| Chlorthalidone | 18 | $430 |
| Valsartan | 24 | $362 |
| Rosuvastatin Calcium | 29 | $337 |
| Lisinopril | 52 | $323 |
| Pantoprazole Sodium | 17 | $308 |
| Losartan Potassium | 31 | $297 |
| Omeprazole | 11 | $143 |
| Furosemide | 16 | $123 |
| Amlodipine Besylate | 22 | $102 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Manhasset
- Mitchell WeinbergManhasset$145K
- Michael KimManhasset$136K
- Sahil ParikhNew York$1.6M
- Deepak BhattNew York$1.6M
- Martin LeonNew York$1.5M
- Evan ShlofmitzRoslyn$951K
- Mohamed Azeem LatibBronx$816K
- Yili HuangElmhurst$699K
- Ali HaiderAstoria$492K
- Sripal BangaloreNew York$482K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.